Clinical Trials Directory

Trials / Conditions / Waldenström's Macroglobulinemia

Waldenström's Macroglobulinemia

8 registered clinical trials studyying Waldenström's Macroglobulinemia — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström
NCT07169331
BeiGenePhase 4
UnknownA Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subject
NCT05979948
Shanghai Changzheng HospitalPhase 2
RecruitingZanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lym
NCT05326308
iOMEDICO AG—
RecruitingR-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia
NCT03697356
Kosin University Gospel HospitalPhase 2
CompletedA Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM)
NCT03053440
BeiGenePhase 3
CompletedIbrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia
NCT02165397
Pharmacyclics LLC.Phase 3
CompletedEfficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
NCT01788020
University of UlmPhase 3
CompletedA Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia
NCT00398710
AEterna ZentarisPhase 2